SPON1 Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer’s Disease Mouse Model

Alzheimer’s disease (AD) is a complex, age-related neurodegenerative disease that is the most common form of dementia. However, the cure for AD has not yet been founded. The accumulation of amyloid beta (Aβ) is considered to be a hallmark of AD. Beta-site amyloid precursor protein cleaving enzyme 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soo Yong, Kang, Joo Yeong, Lee, Taehee, Nam, Donggyu, Jeon, Chang-Jin, Kim, Jeong Beom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290723/
https://www.ncbi.nlm.nih.gov/pubmed/32455709
http://dx.doi.org/10.3390/cells9051275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290723/
https://www.ncbi.nlm.nih.gov/pubmed/32455709
http://dx.doi.org/10.3390/cells9051275

Ejemplares similares